ArticleRevista peruana de medicina experimental y salud publica2026
In vitro antioxidant and anti-inflammatory activities and total polyphenol and flavonoid contents of Anadenanthera colubrina from northern Peru.
Article in Revista peruana de medicina experimental y salud publica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Objectives: To evaluate the in vitro antioxidant and anti-inflammatory activity of the hydroethanolic extract of the bark of Anadenanthera colubrina from northern Peru, as well as its total polyphenol (TPC) and flavonoid (TFC) contents. Materials and methods: Antioxidant activity was evaluated using chemical assays for 2,2-diphenyl-1-picrylhydrazyl (DPPH●) radical scavenging and ferric reducing antioxidant power (FRAP), as well as by measuring lipid peroxidation (formation of thiobarbituric acid reactive substances, TBARS) and H2O2-induced hemolysis. Anti-inflammatory activity was determined through heat-induced ovalbumin denaturation and hypotonicity-induced hemolysis assays. Results: The extract showed high antioxidant activity in both the DPPH●radical scavenging assay (747.6 mg Trolox equivalents/gram of dry extract) and the FRAP assay (435.9 mg FeSO4 equivalents/gram of dry extract). The extract (50 to 1000 μg/mL) inhibited lipid peroxidation, H2O2-induced hemolysis, and ovalbumin denaturation. No activity was observed in the hypotonicity-induced hemolysis assay. TPC and TFC were 642.7 mg gallic acid equivalents/gram and 416.2 mg catechin equivalents/gram of dry extract, respectively. Conclusions: These activities were reported for the first time for A. colubrina from northern Peru, suggesting that the hydroethanolic extract of A. colubrina bark possesses significant preliminary in vitro antioxidant and anti-inflammatory properties and that the high polyphenol and flavonoid contents may be responsible, at least partially, for these activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.